81
68
Growth Score 81 in past quarter
-7 pts
Heat Score 68 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
509544
Blackstone Ventures Inc. has engineered a reverse takeover acquisition of Lattice Biologics, a medical technology company.
David M. Douglas: Chief Financial Officer
Donald A. McInnes: Founder, President and CEO
About the Company
Blackstone Ventures Inc. has engineered a reverse takeover acquisition of Lattice Biologics, a medical technology company headquartered in Scottsdale, Arizona.
There will be meeting of BLV shareholders in Vancouver on Friday November 6, 2015 to approve the transaction.
